title: Localized β-adrenergic receptor blockade does not affect sweating during exercise.
abstract: The purpose of the current study was to determine the effect of a locally administered nonselective β-adrenergic antagonist on sweat gland function during exercise. Systemically administered propranolol has been reported to increase, decrease, or not alter sweat production during exercise. To eliminate the confounding systemic effects associated with orally administered propranolol, we used iontophoresis to deliver it to the eccrine sweat glands within a localized area on one forearm prior to exercise. This allowed for determination of the direct effect of β-adrenergic receptor blockade on sweating during exercise. Subjects (n = 14) reported to the laboratory (23 ± 1°C, 35 ± 3% relative humidity) after having refrained from exercise for ≥12 h. Propranolol (1% solution) was administered to a 5-cm(2) area of the flexor surface of one forearm via iontophoresis (1.5 mA) for 5 min. A saline solution was administered to the opposing arm via iontophoresis. Each subject then exercised on a motor-driven treadmill at 75% of their age-predicted maximal heart rate for 20 min, while sweat rate was measured simultaneously in both forearms. Immediately after cessation of exercise, the number of active sweat glands was measured by application of iodine-impregnated paper to each forearm. The sweat rate for the control and propranolol-treated forearm was 0.62 ± 41 and 0.60 ± 0.44 (SD) mg·cm(-2)·min(-1), respectively (P = 0.86). The density of active sweat glands for the control and propranolol-treated forearm was 130 ± 6 and 134 ± 5 (SD) glands/cm(2), respectively, (P = 0.33). End-exercise skin temperature was 32.9 ± 0.2 and 33.1 ± 0.3°C for the control and propranolol-treated forearm, respectively (P = 0.51). Results of the current study show that when propranolol is administered locally, thus eliminating the potential confounding systemic effects of the drug, it does not directly affect sweating during the initial stages of high-intensity exercise in young, healthy subjects.
authors.affiliation: San Diego State University, San Diego, CA 92182, USA. mbuono@mail.sdsu.edu
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Buono
authors.forename: Brian
authors.initials: B
authors.lastname: Tabor
authors.forename: Ailish
authors.initials: A
authors.lastname: White
mesh_terms: D000279:Administration, Cutaneous; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D004439:Eccrine Glands / Q000187:drug effects* / Q000378:metabolism; D015444:Exercise; D005260:Female; D005542:Forearm; D006801:Humans; D007478:Iontophoresis; D008297:Male; D011433:Propranolol / Q000008:administration & dosage*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism; D012881:Skin Temperature / Q000187:drug effects; D013546:Sweating / Q000187:drug effects*; D055815:Young Adult
chemical_list: D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D011433:Propranolol